2m 2m 2m 2m 2m 2m 2m
Zevra (ZVRA)
NASDAQ
$11.06+$0.10 (+0.95%)
Price as of Jun 03, 2026 8:00 PM EDT- $685.1MMarket Cap
- 22.66%1-Year Change
- BiotechnologyIndustry
Zevra (ZVRA)
$11.06+$0.10 (+0.95%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 106.5M +350.91% | 23.6M -14.02% | 27.5M +4,859.27% | -577,000 -102.01% | |
Cost of Revenue | 16.5M +122.22% | 7.4M +151.85% | 2.9M +758.60% | 343,000 N/A | |
Gross Profit | 90.0M +455.65% | 16.2M -33.94% | 24.5M +2,764.78% | -920,000 -103.21% | |
Sales and Marketing Expense | 77.6M +41.46% | 54.9M +59.90% | 34.3M N/A | N/A N/A | |
Research and Development Expense | -12.7M -69.73% | -42.1M +5.75% | -39.8M +6.78% | -37.3M +266.86% | |
Depreciation and Amortization Expense | 4.1M -36.55% | 6.4M +535.09% | 1.0M +6.57% | 944,000 +267.32% | |
Total Operating Expenses | 90.4M -6.81% | 97.0M +25.82% | 77.1M +45.51% | 53.0M +153.16% | |
Operating Profit | -62.9M -27.65% | -87.0M +75.40% | -49.6M +16.70% | -42.5M -649.94% | |
Interest Income | 7.6M +139.73% | 3.2M N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -1.5M +348.06% | -335,000 +48.23% | |
Interest Income and Expense and Net | 7.6M +139.73% | 3.2M +310.46% | -1.5M +348.06% | -335,000 +48.23% | |
Total Nonoperating Income and Expense | 149.6M +4,869.56% | -3.1M -188.24% | 3.6M +1,919.89% | 176,000 +101.08% | |
Income before Taxes | 86.7M +196.16% | -90.1M +95.75% | -46.0M +8.79% | -42.3M +396.76% | |
Income Taxes | 3.4M -77.56% | 15.4M N/A | 0 +100.00% | -786,000 -2,411.76% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 83.2M +178.88% | -105.5M +129.13% | -46.0M +10.85% | -41.5M +385.60% | |
Net Income from Continuing Operations Applicable to Common | 86.7M +196.16% | -90.1M +95.75% | -46.0M +10.85% | -41.5M -33.95% | |
Basic EPS and Net Income | 1.40 +161.40% | -2.28 +75.38% | -1.30 +8.33% | -1.20 -43.13% | |
Diluted EPS and Net Income | 1.35 +159.21% | -2.28 +75.38% | -1.30 +8.33% | -1.20 -43.13% | |
Basic Weighted Average Shares | 55.3M +19.59% | 46.3M +30.46% | 35.5M +2.79% | 34.5M +15.87% | |
Diluted Weighted Average Shares | 57.3M +23.81% | 46.3M +30.46% | 35.5M +2.79% | 34.5M +15.87% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 62.4M +84.72% | 33.8M -21.52% | 43.0M -34.24% | 65.5M -41.73% | |
Short-Term Investments | 128.6M +260.13% | 35.7M +44.65% | 24.7M +46.08% | 16.9M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 191.0M +174.85% | 69.5M +2.60% | 67.7M -17.76% | 82.4M -26.69% | |
Total Current Assets | 223.0M +159.23% | 86.0M -1.05% | 86.9M -6.54% | 93.0M -19.15% | |
Accumulated Depreciation | 314,000 -81.81% | 1.7M +5.63% | 1.6M +13.24% | 1.4M -25.04% | |
Property and Plant and Equipment and Net | 489,000 +37.36% | 356,000 -51.63% | 736,000 -7.30% | 794,000 -10.18% | |
Total Long-Term Assets | 143,000 -62.76% | 384,000 +308.51% | 94,000 +77.36% | 53,000 -87.90% | |
Total Assets | 284.7M +59.85% | 178.1M +3.37% | 172.3M +49.16% | 115.5M -13.10% | |
Income Taxes Payable | 20.7M +43.71% | 14.4M N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 0 -100.00% | 37.7M N/A | N/A N/A | |
Total Current Liabilities | 39.3M +15.30% | 34.1M -53.79% | 73.7M +528.69% | 11.7M +177.21% | |
Total Long-Term Debt | 61.9M +4.07% | 59.5M +1,074.58% | 5.1M -60.42% | 12.8M N/A | |
Total Long-Term Liabilities | 1.7M -63.00% | 4.6M -37.92% | 7.5M +29,732.00% | 25,000 -19.35% | |
Total Liabilities | 130.1M -6.06% | 138.5M +25.35% | 110.5M +271.65% | 29.7M +410.42% | |
Retained Earnings | -422.1M -16.47% | -505.3M +26.39% | -399.8M +29.56% | -308.6M +15.56% | |
Total Stockholders Equity | 154.7M +289.90% | 39.7M -35.88% | 61.9M -27.90% | 85.8M -32.50% | |
Total Shares Outstanding | 56.9M +5.93% | 53.7M +29.22% | 41.5M +20.25% | 34.5M -1.33% | |
Cash Flow | |||||
Cash from Operating Activities | -1.6M -97.71% | -69.7M +107.74% | -33.5M +79.17% | -18.7M -279.30% | |
Capital Expenditures | 835,000 N/A | 0 -100.00% | 296,000 +218.28% | 93,000 -8.82% | |
Cash from Investing Activities | 18.1M +181.80% | -22.2M +27.44% | -17.4M -52.64% | -36.7M +136.53% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 12.1M -85.31% | 82.1M +188.46% | 28.5M +240.80% | 8.4M -92.62% | |
Financials Ratio | |||||
Gross Margin | 84.52% +23.23% | 68.59% -23.17% | 89.28% -44.01% | 159.45% N/A | |
Operating Margin | -59.12% -83.96% | -368.47% +103.99% | -180.63% -102.45% | 7,366.55% +27,206.48% | |
Return on Assets | 35.96% +159.73% | -60.21% +88.20% | -31.99% -4.32% | -33.44% +181.72% | |
Return on Equity | 85.66% +141.21% | -207.84% +233.26% | -62.37% +59.83% | -39.02% +38.45% | |
Revenue Growth | 350.91% +2,603.64% | -14.02% -100.29% | 4,859.27% +4,863.34% | -102.01% -188.24% | |
Current Ratio | 5.68 +124.83% | 2.53 +114.14% | 1.18 -85.13% | 7.93 -70.83% | |
Cash Ratio | 1.59 +60.20% | 0.99 +69.83% | 0.58 -89.54% | 5.58 -78.98% | |
Debt-to-Equity Ratio | N/A N/A | 1.50 +117.00% | 0.69 N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | 0.33 +34.61% | 0.25 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow